pembrolizumab,lenvatinib
eisai,merck
['hcc', 'lenva', 'pembro']
lenvatinib + pembrolizumab as 1l therapy for ahcc - no improvement in pfs or os 
Professor of Medical Oncology,  Amrita Institute of Medical  Sciences. Oncologist and Hematologist